Peer review process
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the editors and peer reviewers.
Read more about eLife’s peer review process.Editors
- Reviewing EditorJun DingStanford University, Stanford, United States of America
- Senior EditorMichael FrankBrown University, Providence, United States of America
Reviewer #1 (Public review):
Summary:
Tubert C. et al. investigated the role of dopamine D5 receptors (D5R) and their downstream potassium channel, Kv1, in the striatal cholinergic neuron pause response induced by thalamic excitatory input. Using slice electrophysiological analysis combined with pharmacological approaches, the authors tested which receptors and channels contribute to the cholinergic interneuron pause response in both control and dyskinetic mice (in the L-DOPA off state). They found that activation of Kv1 was necessary for the pause response, while activation of D5R blocked the pause response in control mice. Furthermore, in the L-DOPA off state of dyskinetic mice, the absence of the pause response was restored by the application of clozapine. The authors claimed that 1) the D5R-Kv1 pathway contributes to the cholinergic interneuron pause response in a phasic dopamine concentration-dependent manner, and 2) clozapine inhibits D5R in the L-DOPA off state, which restores the pause response.
Strengths
The electrophysiological and pharmacological approaches used in this study are powerful tools for testing channel properties and functions. The authors' group has well-established these methodologies and analysis pipelines. Indeed, the data presented were robust and reliable.
Weaknesses:
Although the paper has strengths in its methodological approaches, there is a significant gap between the presented data and the authors' claims.
The authors answered the most of concerns I raised. However, the critical issue remains unresolved.
I am still not convinced by the results presented in Fig. 6 and their interpretation. Since Clozapine acts as an agonist in the absence of an endogenous agonist, it may stimulate the D5R-cAMP-Kv1 pathway. Stimulation of this pathway should abolish the pause response mediated by thalamic stimulation in SCINs, rather than restoring the pause response. Clarification is needed regarding how Clozapine reduces D5R-ligand-independent activity in the absence of dopamine (the endogenous agonist). In addition, the author's argued that D5R antagonist does not work in the absence of dopamine, therefore solely D5R antagonist didn't restore the pause response. However, if D5R-cAMP-Kv1 pathway is already active in L-DOPA off state, why D5R antagonist didn't contribute to inhibition of D5R pathway?
Since Clozapine is not D5 specific and Clozapine experiments were not concrete, I recommend testing whether other receptors, such as the D2 receptor, contribute to the Clozapine-induced pause response in the L-DOPA-off state.
Reviewer #2 (Public review):
Summary:
This manuscript by Tubert et al. presents the role of D5 receptors (D5R) in regulating the striatal cholinergic interneuron (CIN) pause response through D5R-cAMP-Kv1 inhibitory signaling. Their findings provide a compelling model explaining the "on/off" switch of the CIN pause, driven by the distinct dopamine affinities of D2R and D5R. This mechanism, coupled with varying dopamine states, is likely critical for modulating synaptic plasticity in cortico-striatal circuits during motor learning and execution. Furthermore, the study bridges their previous finding of CIN hyperexcitability (Paz et al., Movement Disorder 2022) with the loss of the pause response in LID mice and demonstrates the restore of the pause through D1/D5 inverse agonism.
Strengths:
The study presents solid findings, and the writing is logically structured and easy to follow. The experiments are well-designed, properly combining ex vivo electrophysiology recording, optogenetics, and pharmacological treatment to dissect / rule out most, if not all, alternative mechanisms in their model.
Weaknesses:
While the manuscript is overall satisfying, one conceptual gap needs to be further addressed or discussed: the potential "imbalance" between D2R and D5R signaling due to the ligand-independent activity of D5R in LID. Given that D2R and D5R oppositely regulate CIN pause responses through cAMP signaling, investigating the role of D2R under LID off L-DOPA (e.g., by applying D2 agonists or antagonists, even together with intracellular cAMP analogs or inhibitors) could provide critical insights. Addressing this aspect would strengthen the manuscript in understanding CIN pause loss under pathological conditions.
Reviewer #3 (Public review):
Summary:
Tubert et al. investigate the mechanisms underlying the pause response in striatal cholinergic interneurons (SCINs). The authors demonstrate that optogenetic activation of thalamic axons in the striatum induces burst activity in SCINs, followed by a brief pause in firing. They show that the duration of this pause correlates with the number of elicited action potentials, suggesting a burst-dependent pause mechanism. The authors demonstrated this burst-dependent pause relied on Kv1 channels. The pause is blocked by a SKF81297 and partially by sulpiride and mecamylamine, implicating D1/D5 receptor involvement. The study also shows that the ZD7288 does not reduce the duration of the pause, and that lesioning dopamine neurons abolishes this response, which can be restored by clozapine.
Weaknesses:
While this study presents an interesting mechanism for SCIN pausing after burst activity, there are several major concerns that should be addressed:
(1) Scope of the Mechanism: It is important to clarify that the proposed mechanism may apply specifically to the pause in SCINs following burst activity. The manuscript does not provide clear evidence that this mechanism contributes to the pause response observed in behavioral animals. While the thalamus is crucial for SCIN pauses in behavioral contexts, the exact mechanism remains unclear. Activating thalamic input triggers burst activity in SCINs, leading to a subsequent pause, but this mechanism may not be generalizable across different scenarios. For instance, approximately half of TANs do not exhibit initial excitation but still pause during behavior, suggesting that the burst-dependent pause mechanism is unlikely to explain this phenomenon. Furthermore, in behavioral animals, the duration of the pause seems consistent, whereas the proposed mechanism suggests it depends on the prior burst, which is not aligned with in vivo observations. Additionally, many in vivo recordings show that the pause response is a reduction in firing rate, not complete silence, which the mechanism described here does not explain. Please address these in the manuscript.
(2) Terminology: The use of "pause response" throughout the manuscript is misleading. The pause induced by thalamic input in brain slices is distinct from the pause observed in behavioral animals. Given the lack of a clear link between these two phenomena in the manuscript, it is essential to use more precise terminology throughout, including in the title, bullet points, and body of the manuscript.
(3) Kv1 Blocker Specificity: It is unclear how the authors ruled out the possibility that the Kv1 blocker did not act directly on SCINs. Could there be an indirect effect contributing to the burst-dependent pause? Clarification on this point would strengthen the interpretation of the results.
(4) Role of D1 Receptors: While it is well-established that activating thalamic input to SCINs triggers dopamine release, contributing to SCIN pausing (as shown in Figure 3), it would be helpful to assess the extent to which D1 receptors contribute to this burst-dependent pause. This could be achieved by applying the D1 agonist SKF81297 after blocking nAChRs and D2 receptors.
(5) Clozapine's Mechanism of Action: The restoration of the burst-dependent pause by clozapine following dopamine neuron lesioning is interesting, but clozapine acts on multiple receptors beyond D1 and D5. Although it may be challenging to find a specific D5 antagonist or inverse agonist, it would be more accurate to state that clozapine restores the burst-dependent pause without conclusively attributing this effect to D5 receptors.
Comments on revisions:
The authors have addressed many of my concerns. However, I remain unconvinced that adding an 'ex vivo' experiment fully resolves the fundamental differences between the burst-dependent pause observed in slices - defined by the duration of a single AHP - and the pause response in CHINs observed in vivo, which may involve contributions from more than one prolonged AHP. In vivo, neurons can still fire action potentials during the pause, albeit at a lower frequency. Moreover, in behaving animals, pause duration does not vary with or without initial excitation. The mechanism proposed demonstrates that the pause duration, defined by the length of a single AHP, is positively correlated with preceding burst activity.
To improve clarity, I recommend using the term 'SCIN pause' to describe the ex vivo findings, distinguishing them more explicitly from the 'pause response' observed in behaving animals. This distinction would help contextualize the ex vivo findings as potentially contributing to, but not fully representing, the pause response in vivo.
Again, it would be helpful to present raw data for pause durations rather than relying solely on ratios. This approach would provide the audience with a clearer understanding of the absolute duration of the burst-dependent pause and allow for better comparison to the ~200 ms pause observed in behaving animals.